92 related articles for article (PubMed ID: 15201934)
1. [Contribution of second-generation azoles in Candida spp. infections].
Lizasoain M; Díaz Pedroche C; Lumbreras C
Rev Esp Quimioter; 2004 Mar; 17(1):105-8. PubMed ID: 15201934
[No Abstract] [Full Text] [Related]
2. Guidelines for treatment of candidiasis.
Pappas PG; Rex JH; Sobel JD; Filler SG; Dismukes WE; Walsh TJ; Edwards JE;
Clin Infect Dis; 2004 Jan; 38(2):161-89. PubMed ID: 14699449
[No Abstract] [Full Text] [Related]
3. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp.
Chiew YF; Inwood H
N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112
[No Abstract] [Full Text] [Related]
4. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
[TBL] [Abstract][Full Text] [Related]
5. [Clinical-microbiological correlation in patients treated with azoles].
Quereda Rodriguez Navarro C
Rev Esp Quimioter; 2004 Mar; 17(1):91-3. PubMed ID: 15201930
[No Abstract] [Full Text] [Related]
6. Drug interactions between cyclosporine and rifampicin, erythromycin, and azoles in kidney recipients with opportunistic infections.
Koselj M; Bren A; Kandus A; Kovac D
Transplant Proc; 1994 Oct; 26(5):2823-4. PubMed ID: 7940889
[No Abstract] [Full Text] [Related]
7. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.
Bassetti M; Righi E; Tumbarello M; Di Biagio A; Rosso R; Viscoli C
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):875-85. PubMed ID: 17140362
[TBL] [Abstract][Full Text] [Related]
8. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452
[TBL] [Abstract][Full Text] [Related]
9. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
10. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
[TBL] [Abstract][Full Text] [Related]
11. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.
Parkins MD; Sabuda DM; Elsayed S; Laupland KB
J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697
[TBL] [Abstract][Full Text] [Related]
12. Trends in fungaemia and antifungal susceptibility in the Netherlands.
Verduyn Lunel F; Koeleman JG; Spanjaard L; Vandenbroucke-Grauls C; Schultz C; Verbrugh HA; Vos G; Troelstra A; Mascini E; Verweij PE; Voss A
Neth J Med; 2006; 64(7):236-42. PubMed ID: 16929085
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
14. Azole susceptibility and resistance in Candida dubliniensis.
Pinjon E; Moran GP; Coleman DC; Sullivan DJ
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
[TBL] [Abstract][Full Text] [Related]
15. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility of non-albicans Candida species causing fingernail onychomycosis.
Upton A; Rogers K; Wood N; Morris AJ
N Z Med J; 2004 Sep; 117(1201):U1060. PubMed ID: 15476017
[No Abstract] [Full Text] [Related]
18. Update on invasive candidiasis.
Rodriguez LJ; Rex JH; Anaissie EJ
Adv Pharmacol; 1997; 37():349-400. PubMed ID: 8891107
[No Abstract] [Full Text] [Related]
19. Invasive Candida infections in the neonate.
Brian Smith P; Steinbach WJ; Benjamin DK
Drug Resist Updat; 2005 Jun; 8(3):147-62. PubMed ID: 16002326
[TBL] [Abstract][Full Text] [Related]
20. Fungal nail infections: diagnosis and management.
Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
